|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
Ophthalmic_business_of_Merck_&_Co.
|
|
gptkbp:CEO
|
Akihiro_Santen
|
|
gptkbp:clinicalTrials
|
Yes
|
|
gptkbp:employees
|
Approximately 2,000
|
|
gptkbp:founded
|
1890
|
|
gptkbp:founder
|
gptkb:Noboru_Santen
|
|
gptkbp:headquarters
|
gptkb:Osaka
gptkb:Osaka,_Japan
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Santen Pharmaceutical
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:keyPeople
|
gptkb:Yoshihiro_Kato
gptkb:Hiroshi_Matsuda
gptkb:Takahiro_Matsuda
gptkb:Yoshihiro_Nishida
gptkb:Takahiro_Matsumoto
gptkb:Hiroshi_Takeda
gptkb:Yoshihiro_Matsumoto
gptkb:Toshiyuki_Takahashi
gptkb:Takahiro_Nishida
gptkb:Hiroshi_Matsumoto
gptkb:Hiroshi_Saito
gptkb:Yoshihiro_Matsuda
gptkb:Yoshihiro_Saito
gptkb:Hiroshi_Yamamoto
gptkb:Hiroshi_Nishida
gptkb:Toshiyuki_Matsumoto
gptkb:Toshio_Saito
gptkb:Takahiro_Saito
Yoshihiro Takeda
Yoshihiro Takahashi
Masahiro Kato
Toshio Takeda
Akihiro_Santen
|
|
gptkbp:market
|
Global
|
|
gptkbp:partnerships
|
gptkb:Bausch_+_Lomb
Novartis
|
|
gptkbp:products
|
Eye drops
|
|
gptkbp:researchAndDevelopment
|
Yes
|
|
gptkbp:revenue
|
¥100 billion (approx.)
|
|
gptkbp:specializesIn
|
Ophthalmology
|
|
gptkbp:stockExchange
|
gptkb:Tokyo_Stock_Exchange
|
|
gptkbp:subsidiary
|
gptkb:Santen_Inc.
gptkb:Santen_SA
|
|
gptkbp:website
|
www.santen.com
|